Paşaoglu H, Inci Karaküçük E, Kurtşoy A, Paşaoğlu A
Department of Clinical Biochemistry, Erciyes University, Kayseri, Turkey.
Neuropeptides. 1996 Feb;30(1):47-51. doi: 10.1016/s0143-4179(96)90054-2.
The changes in the cerebrospinal fluid (CSF) beta-endorphin (beta-end) levels within 24 h following the trauma were examined in 45 patients with head injuries. CSF samples obtained from 25 healthy subjects who had minor surgical operations under spinal anaesthesia were included as the controls. Patients with head injuries were evaluated according to their Glasgow Coma Scale (GCS) scores on admission to the neurosurgery clinic and four subgroups were formed as follows: Group I: minor head trauma (GCS: 13-15) without skull fracture; Group II: mild head injury (GCS: 13-15) with skull fracture; Group III: moderate head injury (GCS: 8-12) and Group IV: severe head injury (GCS: < 8). All patients with head injury had significantly higher CSF beta-end levels than the controls (P < 0.001). The levels in patients with mild head injury (Group II) were significantly higher than those with severe head trauma (Group IV) (P < 0.001). There was not any correlation between the CSF beta-end changes and the GCS scores of the patients. Endogenous opioid peptides are suggested to have a role in central nervous system (CNS) injuries. However, the CSF levels of beta-end in patients with varying degrees of head trauma have not yet been clearly documented in the literature. In the present study, significant changes in CSF beta-end levels are detected in patients with a wide range of head trauma (from minor head trauma to severe injury); however, the increased CSF beta-end levels were not correlated to the early prognosis of the patients.
对45例颅脑损伤患者伤后24小时内脑脊液(CSF)β-内啡肽(β-end)水平的变化进行了研究。选取25例在脊髓麻醉下接受小手术的健康受试者的脑脊液样本作为对照。根据神经外科门诊入院时的格拉斯哥昏迷量表(GCS)评分对颅脑损伤患者进行评估,并分为以下四个亚组:第一组:无颅骨骨折的轻度颅脑外伤(GCS:13 - 15);第二组:有颅骨骨折的轻度颅脑损伤(GCS:13 - 15);第三组:中度颅脑损伤(GCS:8 - 12);第四组:重度颅脑损伤(GCS:< 8)。所有颅脑损伤患者的脑脊液β-end水平均显著高于对照组(P < 0.001)。轻度颅脑损伤患者(第二组)的β-end水平显著高于重度颅脑外伤患者(第四组)(P < 0.001)。脑脊液β-end变化与患者的GCS评分之间无相关性。内源性阿片肽被认为在中枢神经系统(CNS)损伤中起作用。然而,不同程度颅脑外伤患者脑脊液β-end水平在文献中尚未有明确记载。在本研究中,在广泛的颅脑外伤患者(从轻度颅脑外伤到重度损伤)中检测到脑脊液β-end水平有显著变化;然而,脑脊液β-end水平升高与患者的早期预后无关。